Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen T Liby

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Dose-Response : a Publication of International Hormesis Society|March 25, 2014
Synthetic triterpenoids can protect against toxicity without reducing the efficacy of treatment with Carboplatin and Paclitaxel in experimental lung cancerKaren T Liby
International Journal of Molecular Sciences|March 28, 2024
<i>KEAP1</i>-Mutant Lung Cancers Weaken Anti-Tumor Immunity and Promote an M2-like Macrophage PhenotypeChristopher J Occhiuto, Karen T Liby
Cancer Prevention Research (Philadelphia, Pa.)|March 14, 2013
Is lycopene an effective agent for preventing prostate cancer?Michael B Sporn, Karen T Liby
Current Protocols in Pharmacology|October 17, 2018
Murine Models of Pancreatitis Leading to the Development of Pancreatic CancerAna S Leal, Karen T Liby
International Journal of Molecular Sciences|September 28, 2024
The BRD4 Inhibitor I-BET-762 Reduces HO-1 Expression in Macrophages and the Pancreas of MiceAna S Leal, Karen T Liby
Antioxidants (Basel, Switzerland)|June 27, 2024
The Triterpenoid CDDO-Methyl Ester Reduces Tumor Burden, Reprograms the Immune Microenvironment, and Protects from Chemotherapy-Induced Toxicity in a Preclinical Mouse Model of Established Lung CancerJessica A Moerland, Karen T Liby
Nature Clinical Practice. Oncology|October 6, 2005
Cancer chemoprevention: scientific promise, clinical uncertaintyMichael B Sporn, Karen T Liby
Current Topics in Medicinal Chemistry|June 21, 2016
Rexinoids for prevention and treatment of cancer: opportunities and challengesKaren T Liby, Michael B Sporn
Pharmacological Reviews|September 12, 2012
Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic diseaseKaren T Liby, Michael B Sporn
Nature Reviews. Cancer|July 20, 2012
NRF2 and cancer: the good, the bad and the importance of contextMichael B Sporn, Karen T Liby
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Dose-Response : a Publication of International Hormesis Society|March 25, 2014
Synthetic triterpenoids can protect against toxicity without reducing the efficacy of treatment with Carboplatin and Paclitaxel in experimental lung cancerKaren T Liby
International Journal of Molecular Sciences|March 28, 2024
<i>KEAP1</i>-Mutant Lung Cancers Weaken Anti-Tumor Immunity and Promote an M2-like Macrophage PhenotypeChristopher J Occhiuto, Karen T Liby
Cancer Prevention Research (Philadelphia, Pa.)|March 14, 2013
Is lycopene an effective agent for preventing prostate cancer?Michael B Sporn, Karen T Liby
Current Protocols in Pharmacology|October 17, 2018
Murine Models of Pancreatitis Leading to the Development of Pancreatic CancerAna S Leal, Karen T Liby
International Journal of Molecular Sciences|September 28, 2024
The BRD4 Inhibitor I-BET-762 Reduces HO-1 Expression in Macrophages and the Pancreas of MiceAna S Leal, Karen T Liby
Antioxidants (Basel, Switzerland)|June 27, 2024
The Triterpenoid CDDO-Methyl Ester Reduces Tumor Burden, Reprograms the Immune Microenvironment, and Protects from Chemotherapy-Induced Toxicity in a Preclinical Mouse Model of Established Lung CancerJessica A Moerland, Karen T Liby
Nature Clinical Practice. Oncology|October 6, 2005
Cancer chemoprevention: scientific promise, clinical uncertaintyMichael B Sporn, Karen T Liby
Current Topics in Medicinal Chemistry|June 21, 2016
Rexinoids for prevention and treatment of cancer: opportunities and challengesKaren T Liby, Michael B Sporn
Pharmacological Reviews|September 12, 2012
Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic diseaseKaren T Liby, Michael B Sporn
Nature Reviews. Cancer|July 20, 2012
NRF2 and cancer: the good, the bad and the importance of contextMichael B Sporn, Karen T Liby
Pageof 9